Progyny (PGNY) Tops Q2 EPS by 26c; offers guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/9/2026
- Harry and Meghan surprised by King Charles' letter on their status
- Citi initiates UiPath coverage with Buy rating and $23 target
- S&P 500 falls as AI worries hit software makers
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Progyny (PGNY) PT Lowered to $33 at Truist Securities
August 7, 2024 6:30 AM EDTTruist Securities analyst Jailendra Singh lowered the price target on Progyny (NASDAQ: PGNY) to $33.00 (from $37.00) while maintaining a Buy rating.
The analyst comments "We had a post-quarterly conference call with PGNY management to discuss 2Q24 results, ART cycles per utilizer trends, its 2024... More
BTIG Downgrades Progyny (PGNY) to Neutral
August 7, 2024 5:23 AM EDTBTIG analyst David Larsen downgraded Progyny (NASDAQ: PGNY) from Buy to Neutral.
The analyst comments "We are downgrading Progyny (PGNY) to Neutral, following the company's 2Q:24 earnings report. 2Q24 revenue of $304.1M compares to BTIG / consensus of $306.5M / $305M, and EBITDA of $54.5M compares to BTIG / consensus of $53M/ $53M. Despite the... More
